- Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
- Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
- Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
- Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
Marielle Herzog, our Research & Development Director joined us in 2011. Her journey from molecular biology to pioneering nucleosomics research is nothing short of inspiring. Watch Marielle’s video for insights on her career path, the growth of Volition, and her belief in the power of dedication and teamwork.
Marielle’s journey at Volition demonstrates that curiosity, dedication, and teamwork fuel innovation in epigenetic research. As we continue to push the boundaries of science, Marielle plays an integral role at Volition, helping us to drive progress and fulfil our mission of saving lives and improving outcomes for millions of people and animals worldwide.
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields